Ardelyx: Q3 Earnings Snapshot
Published . Updated .
Covered by 2 outlets: Yahoo Finance, KTVB.
Who covered it: Center 1 · Not rated 1. How we rate outlets
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- ARDX Ardelyx
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Ardelyx belongs to, so it often moves with news about it.
- LLY Eli Lilly and
Eli Lilly and is a peer of Ardelyx in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson
Johnson & Johnson is a peer of Ardelyx in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie
AbbVie is a peer of Ardelyx in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck
Merck is a peer of Ardelyx in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories
Abbott Laboratories is a peer of Ardelyx in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ARDX | +1.80% | -0.98% | base | +7.21% | -2.46% | -5.74% | -3.77% |
| XLV | -2.31% | +0.48% | base | +3.08% | +0.65% | +0.47% | +2.39% |
| LLY | -8.25% | +0.73% | base | +0.62% | -2.48% | -3.88% | +0.21% |
| JNJ | +2.19% | +2.93% | base | +3.82% | +2.34% | +3.82% | +5.99% |
| ABBV | +0.42% | +3.41% | base | +2.66% | +1.15% | +1.97% | +2.59% |
| MRK | -1.72% | +4.16% | base | +3.94% | +1.84% | +1.45% | +2.81% |
| ABT | -5.79% | -2.52% | base | +5.93% | +3.79% | +0.53% | +1.02% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Ardelyx: Q3 Earnings Snapshot Yahoo Finance UK
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | +2.66% | final price |
| ABBV | the next day | +1.15% | final price |
| ABBV | two days later | +1.97% | final price |
| ABBV | three days later | +2.59% | final price |
| ABBV | three days earlier | +3.41% | final price |
| ABBV | five days earlier | +0.42% | final price |
| ABT | that day | +5.93% | final price |
| ABT | the next day | +3.79% | final price |
| ABT | two days later | +0.53% | final price |
| ABT | three days later | +1.02% | final price |
| ABT | three days earlier | -2.52% | final price |
| ABT | five days earlier | -5.79% | final price |
| ARDX | that day | +7.21% | final price |
| ARDX | the next day | -2.46% | final price |
| ARDX | two days later | -5.74% | final price |
| ARDX | three days later | -3.77% | final price |
| ARDX | three days earlier | -0.98% | final price |
| ARDX | five days earlier | +1.80% | final price |
| JNJ | that day | +3.82% | final price |
| JNJ | the next day | +2.34% | final price |
| JNJ | two days later | +3.82% | final price |
| JNJ | three days later | +5.99% | final price |
| JNJ | three days earlier | +2.93% | final price |
| JNJ | five days earlier | +2.19% | final price |
| LLY | that day | +0.62% | final price |
| LLY | the next day | -2.48% | final price |
| LLY | two days later | -3.88% | final price |
| LLY | three days later | +0.21% | final price |
| LLY | three days earlier | +0.73% | final price |
| LLY | five days earlier | -8.25% | final price |
| MRK | that day | +3.94% | final price |
| MRK | the next day | +1.84% | final price |
| MRK | two days later | +1.45% | final price |
| MRK | three days later | +2.81% | final price |
| MRK | three days earlier | +4.16% | final price |
| MRK | five days earlier | -1.72% | final price |
| XLV | that day | +3.08% | final price |
| XLV | the next day | +0.65% | final price |
| XLV | two days later | +0.47% | final price |
| XLV | three days later | +2.39% | final price |
| XLV | three days earlier | +0.48% | final price |
| XLV | five days earlier | -2.31% | final price |
Congressional trades in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 14 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 27 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 34 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 27 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 50 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 76 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 27 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 32 days before publication. Filed 27 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “Ardelyx: Q3 Earnings Snapshot” looks
25 out of 100
“Ardelyx: Q3 Earnings Snapshot” scores 25 out of 100. The score uses 2 sources.